Anaphylactic shock

Cardiac Arrest: The Science and Practice of Resuscitation Medicine

Volumn , Issue , 2007, Pages 1103-1117

  Pumphrey, Richard ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67249128157     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544828.064     Document Type: Chapter

References (168)

1. Richet, C.R. Lanaphylaxie. Paris, 1909; Chapter 1. English translation: Murray Bligh, J. Anaphylaxis. Liverpool-London: Constable & Co Ltd, The University Press, 1913; 1.
2. Prausnitz, C. & Kustner, H. Studien uber die Uberempfind-lichkeit. Zentralbl Bakt Parasits Infect I Abt Orig 1921; 86: 160-169.
3. Ishizaka, K., Ishizaka, T. & Hornbrook, M.M. Physico-chemical properties of reaginic antibody. V. Correlation of reaginic activity with cE-globulin antibody. J. Immunol. 1966; 97: 840.
4. Gell, P.G.H. & Coombes, R.R.A.(eds.) Clinical Aspects of Immunology. Oxford: Blackwell, 1962.
5. Johansson, S.G.O., Hourihane, J.O.B., Bousquet, J. et al. A revised nomenclature for allergy [An EAACI position state-ment from the EAACI nomenclature task force] Allergy 2001: 56: 813-824.
6. Hanzlik, P.J. & Karsner, H.A.T. Anaphylactoid phenomena from the intravenous administration of various colloids, arsenicals and other agents. J. Pharmacol. Exp. Ther. 1920; 14: 379.
7. Johansson, S.G.O., Bieber, T., Dahl, R. et al. Revised nomen-clature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J. Allergy Clin. Immunol. 2004; 113: 832-836.
8. Joint Task Force on Practice Parameters. The diagnosis and management of anaphylaxis: An updated practice parameter. J. Allergy Clin. Immunol. 2005; 115: S483-S523.
9. Pumphrey, R.S.H. Lessons for management of anaphylaxis from a study of fatal reactions. Clin. Exp. Allergy 2000; 30: 1144-1150.
10. Roberts, G., Patel, N., Levi-Schaffer, F., Habibi, P. & Lack, G. Food allergy as a risk factor for life-threatening asthma in childhood: A case-controlled study. J. Allergy Clin. Immunol. 2003; 112: 168-174.
11. Warrier, M.R., Copilevitz, C.A., Dykewicz, M.S. & Slavin, R.G. Fresh frozen plasma in the treatment of resistant angiotensin-converting enzyme inhibitor angioedema. Ann. Allergy Asthma Immunol. 2004; 92: 573-575.
12. Pumphrey, R.S.H. Fatal posture in anaphylactic shock. J. Allergy Clin. Immunol. 2003; 112: 451-452.
13. Mills, E.N. & Breiteneder, H. Food allergy and its relevance to industrial food proteins. Biotechnol. Adv. 2005; 23: 409-414.
14. Taylor, S.L. Emerging problems with food allergens. Food, Nutri. Agric. 2000; 26: 14-23.
15. Ballmer-Weber, B.K., Vieths, S., Luttkopf, D., Heuschmann, P. & Wuthrich, B. Celery allergy confirmed by double-blind, placebo-controlled food challenge: A clinical study in 32 subjects with a history of adverse reactions to celery root. J. Allergy Clin. Immunol. 2000; 106: 373-378.
16. Hamamoto, T. Food and agricultural import regulations and standards: Revised allergen labeling requirements. Global Agriculture Information Network: 2005; report JA5037.
17. Sampson, H.A. Food allergy. Part 1: Immunopathogenesis and clinical disorders. J. Allergy Clin. Immunol. 1999; 103: 717-728.
18. Pumphrey, R.S. Fatal anaphylaxis in the UK, 1992-2001. Novartis Found. Symp. 2004; 257: 116-128.
19. Grundy, J., Bateman, B.J., Gant, C., Matthews, S.M., Dean T.P. & Arshad, S. Peanut allergy in three year old children-a pop-ulation based study [abstract]. J. Allergy Clin. Immunol. 2001; 107: S231.
20. Sicherer, S.H., Munoz-Furlong, A. & Sampson, H.A. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: A 5-year follow-up study. J. Allergy Clin. Immunol. 2003; 112: 1203-1207.
21. Bock, S.A., Munoz-Furlong, A. & Sampson, H.A. Fatalities due to anaphylactic reactions to foods. J. Allergy Clin. Immunol. 2001; 107: 191-193.
22. Mata, P., Charpin, D., Charpin, C., Lucciani, P. & Vervloet, D. Fel d I allergen: Skin and or saliva? Ann. Allergy 1992; 69: 321-322.
23. Erwin, E.A., Woodfolk, J.A., Custis, N. & Platts-Mills, T.A. Animal danders. Immunol Allergy Clin. North Am. 2003; 23: 469-481.
24. Nieuwenhuijsen, M.J., Putcha, V., Gordon, S. et al. Exposure-response relations among laboratory animal workers exposed to rats. Occup. Environ. Med. 2003; 60: 104-108.
25. Guida, G., Nebiolo, F., Heffler, E., Bergia, R. & Rolla, G. Anaphylaxis after a horse bite. Allergy. 2005; 60: 1088-1089.
26. Lim, D.L., Chan, R.M.E., Wen, H., van Bever, H.P.S. & Chua, K.Y. Anaphylaxis after hamster bites-identification of a novel allergen. Clin. Exp. Allergy 2004; 34: 1122-1123.
27. Spitalny, K.C., Farnham, J.E., Witherell, L.E. et al. Alpine slide anaphylaxis. N. Engl. J. Med. 1984; 310: 1034-1037.
28. Borchers, A.T., Keen, C.L. & Gershwin, M.E. Fatalities follow-ing allergen immunotherapy. Clin. Rev. Allergy Immunol. 2004; 27: 147-158.
29. Jarvis, D., Luczynska, C., Chinn, S. et al. Change in prevalence of IgE sensitization and mean total IgE with age and cohort. J. Allergy Clin. Immunol. 2005; 116: 675-682.
30. Edston, E. & Hage-Hamsten, M. Death in anaphylaxis in a man with house dust mite allergy, Int. J. Legal Med. 2003; 117: 299-301.
31. Yeang, H.Y. Natural rubber latex allergens: New developments. Curr. Opin. Allergy Clin. Immunol. 2004; 4: 99-104.
32. Blanco, C., Sanchez-Garcia, F., Torres-Galvan, M.J. et al. Genetic basis of the latex-fruit syndrome: Association with HLA class II alleles in a Spanish population. J. Allergy Clin. Immunol. 2004; 114: 1070-1076.
33. Ownby, D.R., Tomlanovich, M., Sammons, N. & McCullough, J. Anaphylaxis associated with latex allergy during barium enema examinations. Am. J. Roentgenol. 1991; 156: 903-908.
34. Martinez Jabaloyas, J.M., Broseta Rico, E., Ruiz Cerda, J.L., Sanz Chinesta, S., Osca Garcia, J.M. & Jimenez Cruz, J.F. Extracorporeal shockwave lithotripsy in patients with urinary diversion. Actas Urol. Esp. 1995; 19: 143-147.
35. Pumphrey, R.S., Duddridge, M. & Norton, J. Fatal latex allergy. J. Allergy Clin. Immunol. 2001; 107: 558.
36. King, T.P. & Guralnick, M. Hymenoptera allergens. Clin. Allergy Immunol. 2004; 18: 339-453.
37. Bilo, B.M., Rueff, F., Mosbech, H. et al. Diagnosis of Hymenoptera venom allergy. Allergy 2005; 60: 1339-1349.
38. Straumann, F., Bucher, C. & Wuthrich, B. Double sensitization to honeybee and wasp venom: Immunotherapy with one or with both venoms? Value of FEIA inhibition for the identifica-tion of the cross-reacting ige antibodies in double-sensitized patients to honeybee and wasp venom. Int. Arch. Allergy Immunol. 2000; 123: 268-274.
39. Egner, W., Ward, C., Brown, D.L. & Ewan, P.W. The frequency and clinical significance of specific IgE to both wasp (Vespula) and honey-bee (Apis) venoms in the same patient. Clin. Exp. Allergy 1998; 28: 26-34.
40. Mosbech, H. Death caused by wasp and bee stings in Denmark 1960-1980. Allergy 1983; 38: 195-200.
41. Muller, U.R. Insect Sting Allergy: Clinical Picture, Diagnosis and Treatment. Gustav Fischer Verlag /VCH, 1990: 46.
42. Reisman, R.E. & Livingston, A. Late-onset allergic reactions, including serum sickness, after insect stings. J. Allergy Clin. Immunol. 1989; 84: 331-337.
43. Reisman, R.E. Unusual reactions to insect stings. Curr. Opin. Allergy Clin. Immunol. 2005; 5: 355-358.
44. Nouira, S., Elatrous, S., Besbes, L. et al. Neurohormonal activation in severe scorpion envenomation: Correlation with hemodynamics and circulating toxin. Toxicol. Appl. Pharmacol. 2005; 208: 111-116.
45. Togias, A.G., Burnett, J.W., Kagey-Sobotka, A. & Lichtenstein, L.M. Anaphylaxis after contact with a jellyfish. J. Allergy Clin. Immunol. 1985; 75: 672-675.
46. Moffitt, J.E., Venarske, D., Goddard, J., Yates, A.B. & deShazo, R.D. Allergic reactions to Triatoma bites. Ann. Allergy Asthma Immunol. 2003; 91: 122-128.
47. Hemmer, W., Focke, M., Vieluf, D., Berg-Drewniok, B., Gotz, M. & Jarisch, R. Anaphylaxis induced by horsefly bites: Iden-tification of a 69 kd IgE-binding salivary gland protein from Chrysops spp. (Diptera, Tabanidae) by western blot analysis. J. Allergy Clin. Immunol. 1998; 101: 134-136.
48. Holden, T.E. & Sherline, D.M. Bestiality, with sensitization and anaphylactic reaction. Obstet. Gynecol. 1973; 42: 138-140.
49. Shah, A. & Panjabi, C. Human seminal plasma allergy: A review of a rare phenomenon. Clin. Exp. Allergy 2004; 34: 827-838.
50. Lucas, C.D., Hallagan, J.B. & Taylor, S.L. The role of natural color additives in food allergy. Adv. Food Nutr. Res. 2001; 43: 195-216.
51. Wuthrich, B., Kagi, M.K. & Stucker, W. Anaphylactic reactions to ingested carmine (E120). Allergy 1997; 52: 1133-1137.
52. Hagel, I., Di Prisco, M.C., Goldblatt, J. & Le Souef, P.N. The role of parasites in genetic susceptibility to allergy: IgE, helminthic infection and allergy, and the evolution of the human immune system. Clin. Rev. Allergy Immunol. 2004; 26: 75-83.
53. Buyuk, Y., Turan, A.A., Uzun, I., Aybar, Y., Cin, O. & Kurnaz, G. Non-ruptured hydatid cyst can lead to death by spread of cyst content into bloodstream: An autopsy case. Eur. J. Gastroenterol. Hepatol. 2005; 17: 671-673.
54. Dominguez-Ortega, J., Alonso-Llamazares, A., Rodriguez, L. et al. Anaphylaxis due to hypersensitivity to Anisakis simplex. Int. Arch. Allergy Immunol. 2001; 125: 86-88.
55. Welch, H., Lewis, C.N., Weinstein, H.I. & Boeckman, B.B. Severe reactions to antibiotics; a nationwide survey. Antibiotics Annual 1957-1958; 296-309.
56. Pumphrey, R.S. & Davis, S. Underreporting of antibiotic ana-phylaxis may put patients at risk. Lancet 1999; 353: 1157.
57. Romano, A., Gueant-Rodriguez, R.M., Viola, M., Pettinato, R. & Gueant, J.L. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann. Intern. Med. 2004; 141: 16-22.
58. Romano, A., Gueant-Rodriguez, R.M., Viola, M. et al. Diagnosing immediate reactions to cephalosporins. Clin. Exp. Allergy 2005; 35: 1234-1242.
59. Baldo, B.A., Pham, N.H. & Zhao, Z. Chemistry of drug aller-genicity. Curr. Opin. Allergy Clin. Immunol. 2001; 1: 327-335.
60. Florvaag, E., Johansson, S.G., Oman, H. et al. Prevalence of IgE antibodies to morphine. Relation to the high and low inci-dences of NMBA anaphylaxis in Norway and Sweden, respec-tively. Acta Anaesthesiol. Scand. 2005; 49: 437-444.
61. Florvaag, E., Johansson, S.G.O., Oman, H., Harboe, T. & Nopp, A. Pholcodine stimulates a dramatic increase of IgE in IgE-sensitized individuals. Allergy 2006; 61: 49.
62. Simon, R.A. Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs. Curr. Allergy Asthma Rep. 2004; 4: 17-24.
63. Hamad, A.M., Sutcliffe, A.M. & Knox, A.J. Aspirin-induced asthma: Clinical aspects, pathogenesis and management. Drugs 2004; 64: 2417-2432.
64. Bosso, J.V., Schwartz, L.B. & Stevenson, D.D. Tryptase and his-tamine release during aspirin-induced respiratory reactions. J. Allergy Clin. Immunol. 1991; 88: 830-837.
65. Szebeni, J. Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity. Toxicology 2005; 216: 106-121.
66. Ronnau, A.C., Wulferink, M., Gleichmann, E. et al. Anaphylaxis to polyvinylpyrrolidone in an analgesic prepara-tion. Br. J. Dermatol. 2000; 143: 1055-1058.
67. Demoly, P., Botros, H.G., Rabillon, J., David, B. & Bousquet, J. Anaphylaxis to antitetanus toxoid serum. Allergy 2002: 57: 860-861.
68. Patja, A., Makinen-Kiljunen, S., Davidkin, I., Paunio, M. & Peltola, H. Allergic reactions to measles-mumps-rubella vac-cination. Pediatrics 2001; 107: E27.
69. Pool, V., Braun, M.M., Kelso, J.M. et al. Prevalence of anti-gelatin Ig E antibodies in people with anaphylaxis after measles-mumps-rubella vaccine in the United States. Pediatrics 2002; 110(6): E71.
70. Sakaguchi, M., Nakayama, T. & Inouye, S. Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines. J. Allergy Clin. Immunol. 1996; 98: 1058-1061.
71. Lee-Wong, M., Resnick, D. & Chong, K. A generalized reaction to thimerosal from an influenza vaccine. Ann. Allergy Asthma Immunol. 2005; 94: 90-94.
72. Vassallo, R.R. Review: IgA anaphylactic transfusion reactions. Part, I. Laboratory diagnosis, incidence, and supply of IgA-deficient products. Immunohematology 2004; 20: 226-233.
73. Shimada, E., Tadokoro, K., Watanabe, Y. et al. Anaphylactic transfusion reactions in haptoglobin-deficient patients with IgE and IgG haptoglobin antibodies. Transfusion 2002; 42: 766-773.
74. Morcos, S.K. Review article: Acute serious and fatal reactions to contrast media: Our current understanding. Br. J. Radiol. 2005; 78(932): 686-693.
75. Katayama, H., Yamaguchi, K., Kozuka, T., Takashima, T., Seez, P. & Matsuura, K. Adverse reactions to ionic and nonionic contrast media. Radiology 1990; 175: 621-628.
76. Wang, D.Y., Forslund, C., Persson, U. & Wiholm, B.E. Drug attributed anaphylaxis. Pharmacoepidemiol. Drug Saf. 1998; 7: 269-274.
77. Lang, D.M., Alpern, M.B., Visintainer, P.F. & Smith, S.T. Gender risk for anaphylactoid reaction to radiographic contrast media. J. Allergy Clin. Immunol. 1995; 95: 813-817.
78. Kanny, G., Pichler, W., Morisset, M. et al. T cell-mediated reac-tions to iodinated contrast media: Evaluation by skin and lymphocyte activation tests. J. Allergy Clin. Immunol. 2005; 115(1): 179-185.
79. Schwartz, E.E., Glick, S.N., Foggs, M.B. & Silverstein, G.S. Hypersensitivity reactions after barium enema examination. Am. J. Roentgenol. 1984; 143(1): 103-104.
80. Krautheim, A.B., Jermann, T.H. & Bircher, A.J. Chlorhexidine anaphylaxis: Case report and review of the literature. Contact Dermatitis 2004; 50: 113-116.
81. Sokol, W.N. Nine episodes of anaphylaxis following cys-toscopy caused by Cidex OPA (orthophthalaldehyde) high-level disinfectant in 4 patients after cytoscopy. J. Allergy Clin. Immunol. 2004; 114: 392-397.
82. Kunisada, M., Adachi, A., Asano, H., & Horikawa, T. Anaphylaxis due to formaldehyde released from root-canal disinfectant. Contact Dermatitis 2002, 47, 215-218.
83. Commens, C.A. & Greaves, M.W. Tests to establish the diag-nosis in cholinergic urticaria. Br. J. Dermatol. 1978; 98: 47-51.
84. Grant, R.T., Bruce Pearson, R.S. & Comeau, W.J. Observations on urticaria provoked by emotion, by exercise and by warming the body. Clin. Sci. 1936; 2: 253-272.
85. Fukunaga, A., Bito, T., Tsuru, K. et al. Responsiveness to autol-ogous sweat and serum in cholinergic urticaria classifies its clinical subtypes. J. Allergy Clin. Immunol. 2005; 116: 397-402.
86. Matsuo, H., Morimoto, K., Akaki, T. et al. Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis. Clin. Exp. Allergy. 2005; 35: 461-466.
87. Asero, R., Tedeschi, A. & Lorini, M. Histamine release in idio-pathic cold urticaria. Allergy 2002; 57: 1211-1212.
88. Alangari, A.A., Twarog, F.J., Shih, M.C. & Schneider, L.C. Clinical features and anaphylaxis in children with cold urticaria. Pediatrics 2004; 113: E313-e317.
89. Rainio, J. & Penttila, A. Amniotic fluid embolism as cause of death in a car accident-a case report. Forens. Sci. Int. 2003; 137(2-3): 231-234.
90. Nishio, H., Matsui, K., Miyazaki, T., Tamura, A., Iwata, M. & Suzuki, K. A fatal case of amniotic fluid embolism with eleva-tion of serum mast cell tryptase. Forens. Sci. Int. 2002; 126: 53-56.
91. Tufnell, D.J. United Kingdom amniotic fluid and embolism register. Br. J. Obstet. Gynecol. 2005; 112: 1625-1629.
92. Benson, M.D. Anaphylactoid syndrome of pregnancy. Am. J. Obstet. Gynecol. 1996; 175: 749.
93. Goldberg, B.J., Herman, F.F. & Hirata, I. Systemic anaphylaxis due to an oxidation product of p-phenylenediamine in a hair dye. Ann. Allergy 1987; 58: 205-208.
94. Belton, A.L. & Chira, T. Fatal anaphylactic reaction to hair dye. Am. J. Forens. Med. Pathol. 1997; 18(3): 290-292.
95. Pumphrey, R.S. & Stanworth, S.J. The clinical spectrum of anaphylaxis in north-west England. Clin. Exp. Allergy 1996; 26: 1364-1370.
96. Thong, B.Y., Cheng, Y.K., Leong, K.P., Tang, C.Y. & Chng, H.H. Anaphylaxis in adults referred to a clinical immunology/allergy centre in Singapore. Singapore Med. J. 2005; 46: 529-534.
97. De Bruyne, J.A. & Lee, B.W. Anaphylaxis in the Asia Pacific. Allergy Clin. Immunol. Int. 2004; 16: 137-141.
98. Bohlke, K., Davis, R.L., DeStefano, F. et al. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J. Allergy Clin. Immunol. 2004; 113: 536-542.
99. Helbling, A., Hurni, T., Mueller, U.R. et al. Incidence of ana-phylaxis with circulatory symptoms: A study over a 3-year period comprising 940 000 inhabitants of the Swiss Canton Bern. Clin. Exp. Allergy 2004; 34: 285-290.
100. Helbling, A., Hurni, T., Mueller, U.R. et al. Incidence of ana-phylaxis with circulatory symptoms: A study over a 3-year period comprising 940 000 inhabitants of the Swiss Canton Bern. Clin. Exp. Allergy 2004; 34: 285-290.
101. Brown, A.F., McKinnon, D. & Chu, K. Emergency department anaphylaxis: A review of 142 patients in a single year. J. Allergy Clin. Immunol. 2001; 108: 861-866.
102. Cianferoni, A., Novembre, E., Mugnaini, L. et al. Clinical fea-tures of acute anaphylaxis in patients admitted to a university hospital: An 11-year retrospective review (1985-1996). Ann. Allergy Asthma Immunol. 2001; 87: 27-32.
103. Pastorello, E.A., Rivolta, F., Bianchi, M. et al. Incidence of anaphylaxis in the emergency department of a general hospital in Milan. J. Chromatogr B. Biomed. Sci. Appl 2001; 756: 11-17.
104. Novembre, E., Cianferoni, A., Bernardini, R. et al. Anaphylaxis in children: Clinical and allergologic features. Pediatrics 1998; 101: E8.
105. Kemp, S.F., Lockey, R.F., Wolf, B.L. et al. Anaphylaxis. A review of 266 cases. Arch. Intern. Med. 1995; 155: 1749-1754.
106. Yocum, M.W. & Khan, D.A. Assessment of patients who have experienced anaphylaxis: A 3-year survey. Mayo Clin. Proc. 1994; 69: 16-23.
107. Russell, M., Dark, K.A., Cummins, R.W., Ellman, G., Callaway, E. & Peeke, H.V. Learned histamine release. Science 1984; 225(4663): 733-734.
108. Palermo-Neto, J. & Guimaraes, R.K. Pavlovian conditioning of lung anaphylactic response in rats. Life Sci. 2000; 68: 611-623.
109. Finkelman, F.D., Rothenberg, M.E., Brandt, E.B., Morris, S.C. & Strait, R.T. Molecular mechanisms of anaphylaxis: Lessons from studies with murine models. J. Allergy Clin. Immunol. 2005; 115: 449-457.
110. Vercelli, D. Genetic regulation of IgE responses: Achilles and the tortoise. J. Allergy Clin. Immunol. 2005; 116: 60-64.
111. Oliver, J.M., Pfeiffer, J.R., Surviladze, Z. et al. Membrane receptor mapping: The membrane topography of Fc(epsilon)RI signaling. Subcell. Biochem. 2004; 37: 3-34.
112. Iwaki, S., Tkaczyk, C., Metcalfe, D.D. & Gilfillan, A.M. Roles of adaptor molecules in mast cell activation. Chem. Immunol. Allergy 2005; 87: 43-58.
113. Metcalfe, D.D., Baram, D. & Mekori, Y.A. Mast cells. Physiol. Rev. 1997; 77: 1033-1079.
114. Montrucchio, G., Alloatti, G. & Camussi, G. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol. Rev. 2000; 80: 1669-1699.
115. Karasawa, K., Harada, A., Satoh, N., Inoue, K. & Setaka, M. Plasma platelet activating factor-acetylhydrolase (PAF-AH). Prog. Lipid Res. 2003; 42: 93-114.
116. Smith, P.L., Sobotka, A., Bleeker, E.R. et al. Physiologic mani-festations of human anaphylaxis. J. Clin. Invest. 1980; 66: 1072-1080.
117. Kozik, A., Moore, R.B., Potempa, J., Imamura, T., Rapala-Kozik, M. & Travis, J. A novel mechanism for bradykinin pro-duction at inflammatory sites. Diverse effects of a mixture of neutrophil elastase and mast cell tryptase versus tissue and plasma kallikreins on native and oxidized kininogens. J. Biol. Chem. 1998; 273: 33224-33229.
118. Kaplan, A.P., Joseph, K. & Silverberg, M. Pathways for bradykinin formation and inflammatory disease. J. Allergy Clin. Immunol. 2002; 109: 195-209.
119. Leeb-Lundberg, L.M., Marceau, F., Muller-Esterl, W., Pettibone, D.J. & Zuraw, B.L. International union of pharma-cology. XLV. Classification of the kinin receptor family: From molecular mechanisms to pathophysiological conse-quences. Pharmacol. Rev. 2005; 57: 27-77.
120. Ober, A.I., MacLean, J.A. & Hannaway, P.J. Life-threatening anaphylaxis to venom immunotherapy in a patient taking an angiotensin-converting enzyme inhibitor. J. Allergy Clin. Immunol. 2003; 112: 1008-1009.
121. Hermann, K. & Ring, J. The renin angiotensin system and hymenoptera venom anaphylaxis. Clin. Exp. Allergy 1993; 23: 762-769.
122. Nikpoor, B., Duan, Q.L. & Rouleau, G.A. Acute adverse reactions associated with angiotensin-converting enzyme inhibitors: Genetic factors and therapeutic implications. Expert Opin. Pharmacother. 2005; 6: 1851-1856.
123. De Kruif, P. Anaphylatoxin and anaphylaxis: VIII. Primary toxicity of normal serum. J. Inf. Dis. 1917; 20: 717-775.
124. Campbell, W.D., Lazoura, E., Okada, N. & Okada, H. Inactivation of C3a and C5a octapeptides by carboxypepti-dase R and carboxypeptidase N. Microbiol. Immunol. 2002; 46: 131-134.
125. Ring, J. Anaphylactoid reactions to intravenous solutions used for Volume substitution. Clin. Rev. Allergy 1991; 9: 397-414.
126. Ljungstrom, K.G., Revenas, B., Smedegard, G., Hedin, H., Richter, W. & Saldeen, T. Histopathological lung changes in immune complex mediated anaphylactic shock in humans elicited by dextran. Forens. Sci. Int. 1988; 38: 251-258.
127. Hernandez, D., de Rojas, F., Martinez Escribano, C. et al. Fatal dextran-induced allergic anaphylaxis. Allergy 2002: 57: 862-862.
128. Marone, G., de Crescenzo, G., Adt, M., Patella, V., Arbustini, E. & Genovese, A. Immunological characterization and functional importance of human heart mast cells. Immunopharmacology 1995; 31(1): 1-18.
129. Schmidt-Traub, S. & Bamler, K.J. The psychoimmunological association of panic disorder and allergic reaction. Br. J. Clin. Psychol. 1997; 36: 51-62.
130. Choi, I.H., Ha, T.Y., Lee, D.G. et al. Occurrence of dissemi-nated intravascular coagulation (DIC) in active systemic anaphylaxis: Role of platelet-activating factor. Clin. Exp. Immunol. 1995; 100: 390-394.
131. Brazil, E. & MacNamara, A.F. “Not so immediate” hypersensi-tivity-the danger of biphasic anaphylactic reactions. J. Accid. Emerg. Med. 1998; 15: 252-253.
132. Choi, I.W., Kim, Y.S., Kim, D.K., et al. Platelet-activating factor-mediated NF-kappaB dependency of a late anaphy-lactic reaction. J. Exp. Med. 2003; 198: 145-151.
133. Project Team of the Resuscitation Council (UK). Update on the emergency medical treatment of anaphylactic reactions for first medical responders and for community nurses. Emerg. Med. J. 2001; 18: 393-395.
134. Brown, S.G. Cardiovascular aspects of anaphylaxis: Implica-tions for treatment and diagnosis. Curr. Opin. Allergy Clin. Immunol. 2005; 5: 359-364.
135. Sampson, H.A., Mendelson, L. & Rosen, J.P. Fatal and near-fatal anaphylactic reaction to food in children and adoles-cents. N. Engl. J. Med. 1992; 327: 380-384.
136. Kay, L.J. & Peachell, P.T. Mast cell beta2-adrenoceptors. Chem. Immunol. Allergy 2005; 87: 145-153.
137. Chong, L.K., Morice, A.H., Yeo, W.W., Schleimer, R.P. & Peachell, P.T. Functional desensitization of beta agonist responses in human lung mast cells. Am. J. Respir. Cell Mol. Biol. 1995; 13: 540-546.
138. Muller, U. & Haeberli, G. Use of beta-blockers during immunotherapy for hymenoptera venom allergy. J. Allergy Clin. Immunol. 2005; 115: 606-609.
139. Sadana, A., Odonnell, C., Hunt, M.T. & Gavalas, M. Managing acute anaphylaxis. Intravenous adrenaline should be consid-ered because of the urgency of the condition. Br. Med. J. 2000; 320(7239): 937-938.
140. Liu, S., Carpenter, R.L., Chiu, A.A., McGill, T.J. & Mantell, S.A. Epinephrine prolongs duration of subcutaneous infiltration of local anesthesia in a dose-related manner. Correlation with magnitude of vasoconstriction. Reg. Anesth. 1995; 20: 378-384.
141. Hoffman, B.B. & Lefkowitz, R.J. Catecholamines, sympath-omimetics drugs and adrenergic receptor antagonists. In Hardman, J.G., Gilman, A.G. & Limbird, L.E. eds. The Pharmacological Basis of Therapeutics, 9th edn. New York: McGraw-Hill, 1996: 199-248.
142. Wolfel, E.E., Hiatt, W.R., Brammell, H.L. et al. Effects of selec-tive and nonselective beta-adrenergic blockade on mecha-nisms of exercise conditioning. Circulation 1986; 74: 664-674.
143. Simons, F.E., Gu, X. & Simons, K.J. Epinephrine absorption in adults: Intramuscular versus subcutaneous injection. J. Allergy Clin. Immunol. 2001; 108: 871-873.
144. Song, T.T., Nelson, M.R., Chang, J.H., Engler, R.J.M. & Chowdhury, B.A. Adequacy of the epinephrine autoinjector needle length in delivering epinephrine to the intramuscular tissues. Ann. Allergy Asthma Immunol. 2005; 94: 539-542.
145. Tsuda, A., Tanaka, K.A., Huraux, C. et al. The in vitro reversal of histamine-induced vasodilation in the human internal mammary artery. Anesth. Analg. 2001; 93: 1453-1459.
146. Bautista, E., Simons, F.E., Simons, K.J. et al. Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock. Int. Arch. Allergy Immunol. 2002; 128: 151-164.
147. Smith, P., Kagey-Sobotka, A., Bleecker, E.R. et al. Physiologic manifestations of human anaphylaxis. J. Clin. Invest. 1980; 66: 1072-1080.
148. Mink, S.N., Simons, F.E., Simons, K.J., Becker, A.B. & Duke, K. Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs. Clin. Exp. Allergy 2004; 34: 1776-1783.
149. Heytman, M. & Rainbird, A. Use of alpha-agonists for man-agement of anaphylaxis occurring under anaesthesia: Case studies and review. Anaesthesia 2004; 59: 1210-1215.
150. Kill, C., Wranze, E. & Wulf, H. Successful treatment of severe anaphylactic shock with vasopressin. Two case reports. Int. Arch. Allergy Immunol. 2004; 134: 260-261.
151. Thomas, M. & Crawford, I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg. Med. J. 2005; 22: 272-273.
152. Boulain, T., Achard, J.M., Teboul, J.L., Richard, C., Perrotin, D. & Ginies, G. Changes in BP induced by passive leg raising predict response to fluid loading in critically ill patients. Chest 2002; 121(4):1245-1252.
153. Maron, M.B. Dose-response relationship between plasma epinephrine concentration and alveolar liquid clearance in dogs. J. Appl. Physiol. 1998; 85: 1702-1707.
154. Arfi, A.M., Kouatli, A., Al-Ata, J., Arif, H. & Syed, S. Acute myocardial ischemia following accidental intravenous administration of epinephrine in high concentration. Indian Heart J. 2005; 57: 261-264.
155. Pumphrey, R.S. & Nicholls, J.M. Epinephrine-resistant food anaphylaxis. Lancet 2000; 355: 1099.
156. Cheuk, D.K., Chau, T.C. & Lee, S.L. A meta-analysis on intra-venous magnesium sulphate for treating acute asthma. Arch. Dis. Child. 2005; 90: 74-77.
157. Blitz, M., Blitz, S., Beasely, R. et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst. Rev. 2005; 19: CD003898.
158. Calogiuri, G.F., Muratore, L., Nettis, E., Ventura, M.T., Ferrannini, A. & Tursi, A. Anaphylaxis to hydrocortisone hemisuccinate with cross-sensitivity to related compounds in a paediatric patient. Br. J. Dermatol. 2004; 151: 707-708.
159. Granata, A.V., Halickman, J.F. & Borak, J. Utility of military anti-shock trousers (MAST) in anaphylactic shock-a case report. J. Emerg. Med. 1985; 2: 349-351.
160. Oliveira Neto, A.M., Duarte, N.M., Vicente, W.V., Viaro, F. & Evora, P.R. Methylene blue: An effective treatment for contrast medium-induced anaphylaxis. Med. Sci. Monit. 2003; 9: CS102-CS106.
161. Mullins, R.J. Anaphylaxis: Risk factors for recurrence. Clin. Exp. Allergy 2003; 33: 1033-1040.
162. Avery, N.J., King, R.M., Knight, S. & Hourihane, J.O. Assessment of quality of life in children with peanut allergy. Pediatr. Allergy Immunol. 2003; 14: 378-382.
163. Sicherer, S.H., Burks, A.W. & Sampson, H.A. Clinical features of acute allergic reactions to peanut and tree nuts in children. Pediatrics. 1998; 102: E6 (http://www.pediatrics.org/cgi/content/full/102/1/e6).
164. Golden, D.B. Discontinuing venom immunotherapy. Curr. Opin. Allergy Clin. Immunol. 2001; 1: 353-356.
165. Oppenheimer, J.J., Nelson, H.S., Bock, S.A., Christensen, F. & Leung, D.Y. Treatment of peanut allergy with rush immunotherapy. J. Allergy Clin. Immunol. 1992; 90: 256-262.
166. Sicherer, S.H. & Simons, F.E. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. J. Allergy Clin. Immunol. 2005; 115: 575-583.
167. Sicherer, S.H., Forman, J.A. & Noone, S.A. Use assessment of self-administered epinephrine among food-allergic children and pediatricians. Pediatrics 2000; 105: 359-362.
168. Gold, M. & Sainsbury, R. First aid anaphylaxis management in 68 children who were prescribed an epinephrine auto-injec-tor device (EpiPen). J. Allergy Clin. Imunol. 2000; 106: 171-176.